Search Results 21-30 of 15077 for Proto-oncogene
The Proteases in Cancer Lab led by Evette S. Radisky, Ph.D., at Mayo Clinic studies proteases and designs better agents for blocking tumor invasion and the ...
Found PKCiota activates a second oncogene, known as SOX2, to stimulate cancer stem cell growth in lung squamous cell carcinoma. Dr. Fields says the current ...
The Epigenetic Etiology of Human Disease Laboratory at Mayo Clinic is studying epigenetic mutations at the epigenome and transcriptome levels.
Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...
The precision medicine study appears online in Oncogene and focuses on kidney cancer and its metastases. Recent studies of the same epigenomic fingerprint ...
The study, published in the Sept. 10 issue of Cancer Cell, overturns the current belief that a mutation in the KRAS oncogene is enough to initiate pancreatic ...
... oncogenic,” Dr. Anastasiadis says. “We believe that loss of the apical PLEKHA7-microprocessor complex is an early and somewhat universal event in cancer ...
The team is exposing, at the molecular level, the routes that aggressive tumor cells take to adapt and survive high levels of chromosomal instability (CIN). Her ...
Transgenic and gene-targeted mouse models enable Mayo Clinic cancer researchers to study in vivo how the overexpression of specific genes and their mutants is ...
The investigative team developed a novel zebrafish model of neuroblastoma metastasis by overexpressing the human MYCN oncogene and knocking out the GAS7 gene.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.